Aicardi–Goutières syndrome and the type I interferonopathies
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Dissection of the genetic basis of Aicardi-Goutières syndrome has highlighted a fundamental link between nucleic acid metabolism, innate immune sensors and type I interferon induction. This had led to the concept of the human interferonopathies as a broader set of Mendelian disorders in which a constitutive upregulation of type I interferon activity directly relates to disease pathology. Here, we discuss the molecular and cellular basis of the interferonopathies, their categorization, future treatment strategies and the insights they provide into normal physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADAR edits Alu RNA51, and gain of function mutations in MDA5 suggest that RNA-sensing mechanisms are involved in some AGS cases119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“Aicardi–Goutières syndrome (AGS) is a childhood encephalopathy with similarities to SLE and strong IFN-I induction119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“In fact, hypocomplementia is a common feature of type I interferonopathies66,67”
From Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation (2017) · cites this paper as [66]
In the citing paper
“For example, deficits in RNASEH2, an enzyme responsible for removing ribonucleotides from DNA and resolving R‐loops, comprise more than half of AGS diagnoses (Crow & Manel, 2015).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
In the citing paper
“AGS is caused by mutations in genes that regulate nucleic acid metabolism.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
Citations
Cites
1 retracted
MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses
Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X.-D., Wang, J., Choi, J. H., Wang, K.-W., Purrington, T., et al. (2014) · Science · doi:10.1126/science.346.6216.1486 · Cited by 112
RetractedMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationImmune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Research works printed but not linked: 1
- Krivine, A., Tovey, M., Taty-Taty, R. & Lebon, P. Endogenous interferon-α in newborns from HIV seropositive mothers. J. Interferon Res. 12, S151 (1992).
Cited by
Items 501–600 of 931
How RNA editing keeps an I on physiology
Goldeck, M., Gopal, A., Jantsch, M. F., Mansouri, H. R., Rajendra, V., & Vesely, C. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00191.2022 · Cited by 13
Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting
Stergioti, E. M., Manolakou, T., Boumpas, D. T., & Banos, A. (2022) · Biomedicines · doi:10.3390/biomedicines10112820 · Cited by 19
Paračková, Z., Zentsová, I., Vrabcová, P., Šedivá, A., & Bloomfield, M. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109174 · Cited by 16
Wright, M., Goin, D. E., Smed, M. K., Jewell, N. P., Nelson, J. L., Olsen, J., Hetland, M. L., Zoffmann, V., & Jawaheer, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161084 · Cited by 18
“Valine, leucine and isoleucine degradation 27 (42) 0.”
BackgroundTargeting Ribonucleases with Small Molecules and Bifunctional Molecules
Borgelt, L., & Wu, P. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00191 · Cited by 13
Practice and Educational Gaps in Genodermatoses
Schaffer, J. V. (2016) · Dermatologic Clinics · doi:10.1016/j.det.2016.02.007 · Cited by 13
Wang, B. X., Grover, S. A., Kannus, P., Yoon, G., Laxer, R. M., Yeh, E. A., & Fish, E. N. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0117 · Cited by 15
“In light of increased ISG expression, a number of AGS patients develop systemic lupus erythematosus—an autoimmune disease with a type I IFN signature—in early childhood (Rice and others 2007a; Crow and Manel 2015).”
InfluentialGenova, E. C., Cavion, F., Lucafò, M., Pelin, M., Lanzi, G., Masneri, S., Ferraro, R. M., Fazzi, E. M., Orcesi, S., Decorti, G., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1837 · Cited by 14
Barnabei, L., Lamrini, H., Castela, M., Jeremiah, N., Stolzenberg, M., Chentout, L., Jacques, S., Bouafia, A., Magérus-Chatinet, A., Moncan, M., et al. (2020) · bioRxiv · doi:10.1101/2020.04.27.046102 · Cited by 12
“…interferonopathies and is caused by recessive or dominant mutations of genes involved in intracellular nucleic acids homeostasis (such as TREX1, SAMHD1, RNASEH2A/B/C and ADAR1), or in nucleotide sensing such as IFIH1 /MDA5(Crow and Manel 2015; Roers, Hiller, and Hornung 2016; Lee-Kirsch 2017).”
BackgroundGenome instability and crosstalk with the immune response
Chabanon, R. M., Danlos, F. X., Ouali, K., & Postel-Vinay, S. C. (2025) · Genome Medicine · doi:10.1186/s13073-025-01509-6 · Cited by 21
Jones, H. F., Stoll, M., Ho, G., O'Neill, D., Han, V. X., Paget, S., Stewart, K., Lewis, J., Kothur, K., Troedson, C., et al. (2021) · Brain and Development · doi:10.1016/j.braindev.2021.10.001 · Cited by 13
Self-citationGenome integrity and inflammation in the nervous system
Aditi, A., & McKinnon, P. J. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103406 · Cited by 14
IFIH1 loss of function predisposes to inflammatory and SARS‐CoV ‐2‐related infectious diseases
Najm, R., Yavuz, L., Jain, R., Naofal, M. E., Ramaswamy, S., Abuhammour, W., Loney, T., Nowotny, N. R., Alsheikh-Ali, A. A. A., Tayoun, A. N. A., et al. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13373 · Cited by 15
“12 15 Furthermore, autoimmune-and immune-mediated diseases such as multiple sclerosis, 16 type 1 diabetes, 17 sclerosing cholangitis 18,19 and very early-onset inflammatory bowel disease 20 have been linked to IFIH1 loss of function.”
CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future?
Jouret, M., Viel, S., Fournier, B., Benezech, S., Avouac, J., Scherlinger, M., Bélot, A., Nocturne, G., Launay, D., Terrier, B., et al. (2025) · Arthritis Research & Therapy · doi:10.1186/s13075-025-03564-1 · Cited by 13
DNA damage, inflammation and aging: Insights from mice
Arvanitaki, E. S., Stratigi, K., & Garinis, G. A. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.973781 · Cited by 17
“Partial loss-of-function biallelic mutations in RNase H2 genes, an endogenous endoribonuclease that cleaves the RNA strand in RNA-DNA duplexes, are the major cause of the autoinflammatory disorder Aicardi-Goutières syndrome (Crow and Manel, 2015).”
BackgroundLiu, L., & Manley, J. L. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113886 · Cited by 13
“For example, uncontrolled STING activation, which could be caused by the hyper-oligomerization we observed in the absence of V2 in the V2-KO cells, can lead to autoimmune diseases, including Aicardi-Goutières syndrome 57 and STING-associated vasculopathy with onset in infancy.”
Polymorphisms in IFIH1: the good and the bad
Mina, E. D., Rodero, M. P., & Crow, Y. J. (2017) · Nature Immunology · doi:10.1038/ni.3765 · Cited by 13
Self-citationSTING-Mediated Autophagy Is Protective against H2O2-Induced Cell Death
Abdullah, A., Mobilio, F., Crack, P. J., & Taylor, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197059 · Cited by 12
“Type-I interferons (IFNs) are pleiotropic cytokines that have been implicated in neuropathologies, including Gaucher disease [1], Aicardi–Goutieres syndrome [2] and a model of prion disease [3].”
BackgroundHeterogeneity of PNPT1 neuroimaging: mitochondriopathy, interferonopathy or both?
Pennisi, A., Rötig, A., Roux, C., Levy, R., Henneke, M., Gärtner, J., Kısa, P. T., Sarıoğlu, F. C., Yiş, U., Konczal, L. L., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107367 · Cited by 18
Gene therapy for leukodystrophy: progress, challenges and opportunities
Aubourg, P. R. (2016) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2016.1151352 · Cited by 12
Sugimoto, R., Kenzaka, T., Fujikawa, M., Kawasaki, S., & Nishisaki, H. (2020) · Cureus · doi:10.7759/cureus.8626 · Cited by 12
TREX1 exonuclease in immunity and disease
Shang, Z., Wang, L., & Zhou, W. (2025) · International Immunology · doi:10.1093/intimm/dxaf037 · Cited by 16
Tumour-specific STING agonist synthesis via a two-component prodrug system
Hsu, N., Tang, C., Mendes, R. V., Labão‐Almeida, C., dos Reis, C. V., Coelho, A. R., Marques, M. C., Cabeza-Cabrerizo, M., Misteli, R., Rooney, T. P. C., et al. (2025) · Nature Chemistry · doi:10.1038/s41557-025-01930-9 · Cited by 13
Navigating the brain and aging: exploring the impact of transposable elements from health to disease
Breton, A. L., Bettencourt, M. P., & Gendrel, A.-V. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1357576 · Cited by 13
“In addition, IFN-1-induced immune response triggering the expression of interferon stimulated genes is observed in almost all AGS patients, except the ones with RNASEH2B mutations (Crow and Manel, 2015).”
BackgroundEstablished and Emerging Roles of DEAD /H‐Box Helicases in Regulating Infection and Immunity
Parthun, M., Long, M. E., & Hemann, E. A. (2024) · Immunological Reviews · doi:10.1111/imr.13426 · Cited by 13
Ku limits RNA-induced innate immunity to allow Alu expansion in primates
Zhu, Y., Li, A., Maji, S., Lee, B. J., Korn, S. M., Gertie, J. A., Dorrity, T. J., Wang, J., Wang, K. J., Pelletier, A., et al. (2025) · Nature · doi:10.1038/s41586-025-09104-w · Cited by 16
Sudhir, B. J., Keelara, A. G., Venkat, E. H., Kazumata, K., & Sundararaman, A. (2021) · Neurosurgical FOCUS · doi:10.3171/2021.6.focus21281 · Cited by 11
Zhao, J., Li, Y., Ma, J., Liu, J., Xiao, R., Wang, L., Li, P., He, Y., Qian, F., Zhang, A., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114338 · Cited by 11
Phase separation in immune regulation and immune-related diseases
Huang, N., Dong, H., & Shao, B. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02253-9 · Cited by 11
“Drugs targeting 1 3 cGAS-DNA phase separation might be an effective solution for treating AGS and other cGAS-STING pathway–related autoimmune diseases although this postulation requires further investigation.”
BackgroundInfluentialGovender, U., Corre, B., Bourdache, Y., Pellegrini, S., & Michel, F. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a0416-187rr · Cited by 14
Ruaud, L., Rice, G., Cabrol, C., Piard, J., Rodero, M. P., van Eyk, L., Boucher-Brischoux, E., de Noordhout, A. M., Maré, R., Scalais, E., et al. (2018) · Human Mutation · doi:10.1002/humu.23554 · Cited by 14
Self-citationClassification of Genetically Defined Autoinflammatory Diseases
Goldbach‐Mansky, R. T., & de Jesus, A. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-98605-0_10 · Cited by 11
Brain organoids and insights on human evolution
Muotri, A. R. (2019) · F1000Research · doi:10.12688/f1000research.18495.1 · Cited by 12
Negative Regulation of IKKε-Mediated IRF7 Phosphorylation by HSP70
Lee, K. J., Lee, H., & Joo, C. H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900297 · Cited by 11
Mommert, M., Perret, M., Hockin, M. F., Viel, S., Bélot, A., Richard, J., Mezidi, M., Fassier, J., Javouhey, É., ANTOINE Study Group, et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048978 · Cited by 14
Huijser, E., & Versnel, M. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030532 · Cited by 12
“At present, mutations in seven genes have been described to cause Aicardi–Goutières syndrome (AGS), a prototypic autoimmune syndrome [91].”
BackgroundUkadike, K. C., Ni, K., Wang, X., Taylor, M. S., LaCava, J., Pachman, L. M., Eckert, M. M., Stevens, A. M., Lood, C., & Mustelin, T. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02538-3 · Cited by 11
“Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.”
BackgroundEmerging Concepts in Vector Development for Glial Gene Therapy: Implications for Leukodystrophies
von Jonquières, G., Rae, C. D., & Housley, G. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661857 · Cited by 12
“…that RNASEH2C is considered a metastasis susceptibility gene and interfering with the expression of cell cycle regulated genes must be very carefully considered as it may increase downstream risks of malignancies (Crow et al., 2006; Orcesi et al., 2009; Crow and Manel, 2015; Deasy et al., 2019).”
BackgroundCuinat, S., Bézieau, S., Deb, W., Mercier, S., Vignard, V., Isidor, B., Küry, S., & Ebstein, F. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.101130 · Cited by 10
“128 This assumption suggests that both Aicardi e Goutie`res syndrome and neuro-developmental proteasomopathies might share the same underlying pathogenic determinants, although further research is required to confirm this hypothesis formally.”
BackgroundYan, J., Zhao, Y., Du, J., Wang, Y., Wang, S., Wang, Q., Zhao, X., Xu, W., & Zhao, K. (2022) · Mobile DNA · doi:10.1186/s13100-022-00268-0 · Cited by 14
“Mutations in MDA5 have consistently been associated with an autoimmune disease termed Aicardi-Goutières syndrome (AGS) (5, 6).”
BackgroundInfluentialUnpaved roads: How the DNA damage response navigates endogenous genotoxins
Thada, V., & Greenberg, R. A. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103383 · Cited by 15
IRF1 Is Required for MDA5 (IFIH1) Induction by IFN-α, LPS, and poly(I:C) in Murine Macrophages
Aparici‐Herraiz, I., Sanchez, G. S., Batlle, C., Rehues, P., López‐Serrat, M., Estrella, L. V., Lloberas, J., & Celada, A. (2022) · Journal of Innate Immunity · doi:10.1159/000527008 · Cited by 14
“Gain-of-function mutations in the IFIH1 gene are associated with type I interferonopathies, in which type I IFNs are detectable in the cerebrospinal fluid and peripheral blood [29, 31].”
BackgroundDysregulated STAT1 gain-of-function: Pathogen-free autoimmunity and fungal infection
Guo, L., Lian, D., Gu, Y., Lu, X., Zhang, Y., Li, X., Khrustaleva, T. A., Lan, J., Liang, Y., Khrustalev, V. V., et al. (2024) · hLife · doi:10.1016/j.hlife.2024.03.002 · Cited by 12
Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling
Shim, A., Luan, X., Zhou, W., Crow, Y. J., & Maciejowski, J. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae089 · Cited by 10
“TREX1 mutations that truncate the C-terminus disrupt TREX1-ER association while preserving nucleolytic activity, and are associated with a distinct clinical disease referred to as retinal vasculopathy with cerebral leukoencephalopathy (RVCL) (24,25).”
Self-citationCheng, L., Liu, Z., Shen, C., Xiong, Y., Shin, S. Y., Hwang, Y., Yang, S., Chen, Z., & Zhang, X. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70208 · Cited by 11
“The elevated expression of type I IFN and ISG is commonly observed in the CNS and peripheral blood cells of AGS patients [106, 107], and IFN signaling pathway activation is thought to play a central role in brain pathogenesis [108, 109].”
ATP2A2 regulates STING1/MITA-driven signal transduction including selective autophagy
Yang, X., Lv, L., Zhang, Y., Zhang, Z., Zeng, S., Zhang, X., Wang, Q., Dorf, M. E., Li, S., & Fu, B. (2025) · Autophagy · doi:10.1080/15548627.2025.2496786 · Cited by 11
“However, excessive CGAS-STING1 pathway activation is associated with autoinflammatory diseases like Aicardi-Goutières syndrome and systemic lupus erythematosus [7,8].”
The cGAS-STING signaling pathway in the regulation of pulmonary infections: a systematic review
Xu, Q., & Zhu, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1628481 · Cited by 12
“A notable example is the Aicardi-Goutières syndrome (AGS), a leukodystrophy caused by TREX1 mutations that result in chronic IFN-I production via sustained cGAS activation, leading to neuroin fl ammation and immune-mediated demyelination (Giroud et al., 1986; Crow and Manel, 2015).”
Rheumatological manifestations in inborn errors of immunity
Bal, S. K., Pázmándi, J., Boztuǧ, K., & Özen, S. (2019) · Pediatric Research · doi:10.1038/s41390-019-0600-8 · Cited by 11
Nájera, G. S., Narganes-Carlón, D., & Crowther, D. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-94897-9 · Cited by 13
“…and chronic inflammatory diseases like non-alcoholic fatty liver disease 109 , systemic lupus erythematosus 110 , vascular and pulmonary syndrome 111 , macular degeneration 112 , Bloom syndrome 113 , Aicardi-Goutières syndrome 114 , cancer 115 , DNA damage 116 , neurodegeneration 117 and beyond.”
BackgroundEarly recognition of patients with leukodystrophies
Modesti, N. B., Evans, S. H., Jaffe, N., Vanderver, A. L., & Gavazzi, F. (2022) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2022.101311 · Cited by 12
SLE redefined on the basis of molecular pathways
Barturen, G., & Alarcón-Riquelme, M. E. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.006 · Cited by 9
“rare recessive disease caused bymutations in one of several genes, among which TREX1was the first to be identified [43].”
BackgroundJorge, M. S., & Bugiani, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_9 · Cited by 11
Catatonia in a patient with Aicardi-Goutières syndrome efficiently treated with immunoadsorption
Ayrolles, A., Ellul, P., Renaldo, F., Boespflug‐Tanguy, O., Delorme, R., Drunat, S., Elmaleh, M., Kwon, T., Rozenberg, F., Bondet, V., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.064 · Cited by 10
Self-citationAnimal Models for the Study of Nucleic Acid Immunity: Novel Tools and New Perspectives
Vila, I. K., Frétaud, M., Vlachakis, D. P., Laguette, N., & Langevin, C. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.08.016 · Cited by 13
“catabolism have been shown to be responsible for the onset of AGS, including mutations in TREX1 [51], RNASEH2 endonuclease complex, [52], SAMHD1 [53], ADAR [54] and IFIH1 [55, 56].”
BackgroundRutherford, H. A., Kasher, P. R., & Hamilton, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623650 · Cited by 12
“Indeed, in human patients, AGS is often characterized by a period of pronounced symptomatic deterioration followed by stabilization and—in rare cases—small improvements (7, 69).”
BackgroundGenotoxic stress signalling as a driver of macrophage diversity
Kasapi, A., & Triantafyllopoulou, A. (2022) · Cell Stress · doi:10.15698/cst2022.03.265 · Cited by 11
“AGS is part of a broader group of genetic diseases characterized by chronically elevated type I IFNs, systemic autoinflammation and autoimmunity and called ‘interferonopathies’ (reviewed in [73-75]).”
BackgroundSelf or Non-Self? It Is also a Matter of RNA Recognition and Editing by ADAR1
Tassinari, V., Cerboni, C., & Soriani, A. (2022) · Biology · doi:10.3390/biology11040568 · Cited by 13
van der Made, C. I., Hoischen, A., Netea, M. G., & van de Veerdonk, F. L. (2020) · Immunological Reviews · doi:10.1111/imr.12898 · Cited by 11
Exploration of Gross Motor Function in Aicardi-Goutières Syndrome
Gavazzi, F., Glanzman, A. M., Woidill, S., Formanowski, B. L., Dixit, A., Isaacs, D., Kornafel, T., Ballance, E., Pierce, S. R., Modesti, N. B., et al. (2023) · Journal of Child Neurology · doi:10.1177/08830738231188753 · Cited by 10
“Aicardi-Goutières syndrome (AGS) is a heritable interferonopathy that can result in severe neurologic impairment.(1,2) Although rare, Aicardi-Goutières syndrome is among the most commonly identified leukodystrophies in clinical testing.”
BackgroundAdaptive inhibition of CGAS signaling by TREX1
Lira, M. C., Vanpouille‐Box, C., & Galluzzi, L. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.02.001 · Cited by 10
Reverse transcriptase inhibitors in Aicardi–Goutières syndrome: A crossover clinical trial
Crow, Y. J., Briggs, T. A., Eleftheriou, D., Parida, A., Battison, C. G., Giddings, A., Kennel, T., Parker, R. A., & AGS‐RTIs Study Group (2024) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.16199 · Cited by 12
Self-citationKarmon, M., Kopel, E., Barzilai, A., Geva, P., Eisenberg, E., Levanon, E. Y., & Greenberger, S. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.11.010 · Cited by 9
IFIH1 and DDX58 gene variants in pediatric rheumatic diseases
Raupov, R. K., Suspitsin, E. N., Belozerov, K. E., Gabrusskaya, T., & Kostik, M. M. (2023) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v12.i3.107 · Cited by 9
Abnormal regulation of the antiviral response in neurological/neurodegenerative diseases
Lam, M. M. W., Mapletoft, J., & Miller, M. S. (2016) · Cytokine · doi:10.1016/j.cyto.2016.09.002 · Cited by 10
Lindgren, A. A., Filipowicz, A. R., Hattler, J. B., Kim, S. O., Chung, H. K., Kuroda, M. J., Johnson, E. M., & Kim, W. (2018) · AIDS · doi:10.1097/qad.0000000000001793 · Cited by 11
Systemic Expression of a Viral RdRP Protects against Retrovirus Infection and Disease
Miller, C. M., Barrett, B. S., Chen, J., Morrison, J. H., Radomile, C., Santiago, M. L., & Poeschla, E. M. (2020) · Journal of Virology · doi:10.1128/jvi.00071-20 · Cited by 8
“The innate immune system must maintain a delicate balance between mounting an adequate host defense and causing excessive tissue damage (1, 2).”
BackgroundInfluentialAssouvie, A., Rotival, M., Hamroune, J., Busso, D., Roméo, P., Quintana‐Murci, L., & Rousselet, G. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009090 · Cited by 10
“Dysregulated type I interferon expression is the molecular substrate of Aicardi-Goutières syndrome [14], an early onset brain disease associated with signs of inflammation.”
Case Report: Aicardi-Goutières Syndrome Caused by Novel TREX1 Variants
Wu, D., Fang, L., Huang, T., & Ying, S. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.634281 · Cited by 9
“According to the pathogenic genes found, it was divided into seven subtypes: TREX1 (AGS1), RNASEH2B (AGS2), RNASEH2C (AGS3), RNASEH2A (AGS4), SAMHD1 (AGS5), ADAR1 (AGS6), and IFIH1 (AGS7) (2, 9).”
BackgroundInfluentialSevere diarrhea in a 10‐year‐old girl with Aicardi–Goutières syndrome due to IFIH1 gene mutation
Lu, M., Zhu, K., Zheng, Q., Ma, X., & Zou, L. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62397 · Cited by 9
“IFIH1 is a cytosolic receptor for double-stranded RNA (dsRNA) which is also known as Melanoma differentiation-associated protein 5 (Crow & Manel, 2015).”
BackgroundSpectrum of Neuroradiologic Findings Associated with Monogenic Interferonopathies
Benjamin, P., Sudhakar, S. V., D’Arco, F., Löbel, U., Carney, O., Roux, C.-J., Boddaert, N., Hemingway, C. A., Eleftheriou, D., & Mankad, K. (2022) · UCL Discovery (University College London) · Cited by 9
Update on R-loops in genomic integrity: Formation, functions, and implications for human diseases
Zhu, M., Wang, X., Zhao, H., & Wang, Z. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101401 · Cited by 16
Bélot, A., Tusseau, M., Cognard, J., Georgin‐Lavialle, S., Boursier, G., & Hedrich, C. M. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.70003 · Cited by 9
Chai, L., Li, C., Wang, X., Qin, Y., Sun, H., Du, J., Liu, Y., Hu, D., Xiong, J., Zhao, Z., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116336 · Cited by 10
Induction of Samhd1 by interferon gamma and lipopolysaccharide in murine macrophages requires IRF1
Estrella, L. V., López‐Serrat, M., Sánchez‐Sànchez, G., Vico, T., Lloberas, J., & Celada, A. (2020) · European Journal of Immunology · doi:10.1002/eji.201948491 · Cited by 10
Typ-I-Interferonopathien: Durch Typ-1-Interferone bedingte entzündliche Systemerkrankungen
Günther, C., Schmidt, F., König, N., & Lee‐Kirsch, M. A. (2016) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-015-0027-5 · Cited by 11
“ISG15-Defizienz Die ISG15-Defizienz geht ähnlich dem Aicardi-Goutières-Syndrom mit Verkalkungen der Basalganglien sowie variablen neurologischen Symptomen einher.”
BackgroundInfluentialPararajasingam, A., Bradley, R. E., Evans, J., Lowe, A., Goodwin, R., & Jolles, S. R. A. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.837568 · Cited by 8
“However, in contrast to viral infection, AGS is considered to represent an abnormal response to endogenous or self-derived nucleic acids (10).”
BackgroundWiley, C. A., Steinman, R. A., & Wang, Q. (2022) · Brain Pathology · doi:10.1111/bpa.13118 · Cited by 7
Autophagy as a caretaker of nuclear integrity
Boyle, E., & Wilfling, F. (2023) · FEBS Letters · doi:10.1002/1873-3468.14719 · Cited by 10
Neurometabolic and neurodegenerative diseases in children
Radke, J., Stenzel, W., & Goebel, H. H. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00009-2 · Cited by 9
Haskell, G., Mori, M., Powell, C. M., Amrhein, T. J., Rice, G., Bailey, L. A., Strande, N. T., Weck, K. E., Evans, J. P., Berg, J. S., et al. (2018) · Molecular Case Studies · doi:10.1101/mcs.a002758 · Cited by 8
“…RNASEH2C, SAMHD1, ADAR, or IFIH1 show sustained increased expression of type I interferon-stimulated gene transcripts in CSF and serum (interferon signature) (Rice et al. 2013; Crow and Manel 2015), reflecting overactivity of the innate immune system triggered by endogenous nucleic acid pathways.”
BackgroundInfluentialYu, Y., Wang, M., Li, X., Mao, J., Zhu, Y., Wang, N., Yin, L.-H., Guo, Z.-L., Cai, H., Li, T., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01025-3 · Cited by 8
“The loss-of-function mutation of TREX1 have been frequently reported in AGS patients [8].”
BackgroundVasculitis and vasculopathy associated with inborn errors of immunity: an overview
Federici, S., Cinicola, B. L., Torre, F. L., Castagnoli, R., Lougaris, V., Giardino, G., Volpi, S., Caorsi, R., Leonardi, L., Corrente, S., et al. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1258301 · Cited by 11
“Alterations of these genes cause a spectrum of SLE and AGS phenotypes with a wide range of severity and overlapping features (136, 140, 141).”
BackgroundInfluentialSAMHD1 dysfunction induces IL-34 expression via NF-κB p65 in neuronal SH-SY5Y cells
Zhang, L., Wang, W., Chen, T., Cui, J., Li, X., Liu, A., Liu, R., Fang, L., Jiang, J., Li, Y., et al. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.02.003 · Cited by 7
Pathogenic role and diagnostic utility of interferon-α in histiocytic necrotizing lymphadenitis
Kaneko, S., Shimbo, A., Irabu, H., Hatano, M., Takasawa, K., Kamiya, T., Akamine, K., Tanaka, T., Minato, T., Ono, M., et al. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110324 · Cited by 7
Konar, A. D., Shivhare, V., Ahuja, R., Gupta, A., Tiwari, P., Khan, N., Ahirwar, S. K., Mandloi, A. S., Mishra, A., Singh, M., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb01976h · Cited by 7
The epileptology of Aicardi-Goutières syndrome: electro-clinical-radiological findings
GIORGIS, V. D., Varesio, C., Viri, M., Giordano, L., Piana, R. L., Tonduti, D., Roncarolo, F., Masnada, S., Pichiecchio, A., Veggiotti, P., et al. (2020) · Seizure · doi:10.1016/j.seizure.2020.11.019 · Cited by 7
B Cell Intrinsic STING Signaling Is Not Required for Autoreactive Germinal Center Participation
Green, K., Wittenborn, T. R., Hagert, C., Terczyńska‐Dyla, E., van Campen, N., Jensen, L., Reinert, L. S., Hartmann, R., Paludan, S. R., & Degn, S. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.782558 · Cited by 9
Zsurka, G., Appel, M. L. T., Nastaly, M., Hallmann, K., Hansen, N., Nass, D., Baumgartner, T. R., Surges, R., Hartmann, G., Bartok, E., et al. (2023) · Cells · doi:10.3390/cells12020227 · Cited by 8
“Known causes include hypermorphic variants of nucleic acid receptors, such as MDA-5, RIG-I, and STING, and hypomorphic variants of negative regulators of nucleic acid sensing and the antiviral response, including nucleases, such as TREX1 [40], and inhibitors of the type I interferon pathway, such as USP18 [38].”
BackgroundPathogenic Microglia Orchestrate Neurotoxic Properties of Eomes-Expressing Helper T Cells
Zhang, C., Raveney, B. J. E., Takahashi, F., Yeh, T.-W., Hohjoh, H., Yamamura, T., & Oki, S. (2023) · Cells · doi:10.3390/cells12060868 · Cited by 10
“Although IFN-I has been clinically prescribed for preventing RRMS relapses, prolonged neuroinflammatory features of IFN-I are observed in Aicardi–Goutières syndrome (AGS) [27], a rare hereditary disease with a constitutive overexpression of IFN-I due to a monogenic mutation in IFN signal-related genes.”
BackgroundNeurodevelopmental disorders: 2022 update
Sabariego-Navarro, M., Fernández‐Blanco, Á., Sierra, C., & Dierssen, M. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3801 · Cited by 23
Uggenti, C., & Crow, Y. J. (2018) · Cell · doi:10.1016/j.cell.2018.01.023 · Cited by 10
Self-citationApproaches for investigating the extracellular signaling function of ISG15
Swaim, C. D., Canadeo, L. A., & Huibregtse, J. M. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.12.027 · Cited by 7
Leukoencephalopathy, calcifications, and cysts: Labrune syndrome
Waack, A. L., Norris, J., Becker, K., Hoyt, A. T., & Schroeder, J. (2022) · Radiology Case Reports · doi:10.1016/j.radcr.2022.11.026 · Cited by 8
Intercellular communication in the innate immune system through the cGAS-STING pathway
Nandakumar, R., Windross, S. J., & Paludan, S. R. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.007 · Cited by 6
Dysregulation in nucleic acid‐sensing pathway genes is associated with cancer patients’ prognosis
Yan‐Fei, H., Yang, H. K., Zhou, Y., Yang, H., Yu‐Qing, Y., Ipsita, P., Hui-ying, H., Weigang, F., & Tian, X. (2020) · Cancer Science · doi:10.1111/cas.14450 · Cited by 6
Drougkas, K., Smerla, R., Skarlis, C., & Mavragani, C. P. (2023) · Journal of Molecular Pathology · doi:10.3390/jmp4040024 · Cited by 8
Neurophenotype and genetic analysis of children with Aicardi‐Goutières syndrome in China
Zhang, S., Zhang, W., Ding, C., Ren, X., Fang, F., & Wu, Y. (2024) · Pediatric Investigation · doi:10.1002/ped4.12428 · Cited by 6
Inosine: biofunctions and the roles in human diseases
Li, F., Zhang, J., Kang, J., Tong, X., Zhang, P., & Zhu, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1634814 · Cited by 9
Transactions on micronuclear DNA and implications for immune signaling
Maciejowski, J., & Greenberg, R. A. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.10.007 · Cited by 9
Emerging molecular mechanisms of cGAS-STING activation and regulation
Liu, Y., Ma, K., & Jiang, Z. (2026) · Molecular Immunology · doi:10.1016/j.molimm.2026.02.008 · Cited by 6
Metadata
- Authors
- Crow, Y. J., & Manel, N.
- Affiliations
- Inserm (FR)
- Corresponding author
- Crow, Yanick J.
- Venue
- Nature Reviews Immunology
- Published
- 2015-06-05
- Volume
- 15
- Issue
- 7
- Pages
- 429-440
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1542158376
- Cited by
- 925
- References
- 106
- Citations by year
- 2026: 63 · 2025: 80 · 2024: 83 · 2023: 92 · 2022: 103 · 2021: 92 · 2020: 82 · 2019: 80 · 2018: 71 · 2017: 88 · 2016: 75 · 2015: 16
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IDEX-0001, ANR-11-LABX-0043)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- Aicardi-Goutières syndrome, type I interferonopathy, type I interferon, innate immune signaling, monogenic disorders, nucleic acid metabolism, innate immune sensors, interferon induction, interferonopathies, treatment options
- MeSH terms
- Animals, Humans, Interferon Type I, Nervous System Malformations, Autoimmune Diseases of the Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.